The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 14, 2023
Filed:
Jul. 19, 2021
Applicant:
Annexon, Inc., Brisbane, CA (US);
Inventors:
Dean R. Artis, Kensington, CA (US);
Colin P. Leslie, Pozzolengo, IT;
Luca B. Mileo, San Giovanni Lupatoto, IT;
Claudia Beato, Castel D'azzano, IT;
Federico Sorana, Verona, IT;
Bruno Di Guglielmo, Verona, IT;
Chiara Padroni, Villafranca di Verona, IT;
Assignees:
ANNEXON, INC., South San Francisco, CA (US);
APTUIT (VERONA) SRL, Verona, IT;
Primary Examiner:
Int. Cl.
CPC ...
C07F 5/02 (2006.01); A61P 3/00 (2006.01); A61P 29/00 (2006.01); A61P 27/06 (2006.01); A61P 37/06 (2006.01); A61P 25/28 (2006.01); A61P 37/00 (2006.01);
U.S. Cl.
CPC ...
C07F 5/025 (2013.01); A61P 3/00 (2018.01); A61P 25/28 (2018.01); A61P 27/06 (2018.01); A61P 29/00 (2018.01); A61P 37/00 (2018.01); A61P 37/06 (2018.01);
Abstract
Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.